SCHEMBL6207626

SCHEMBL6207626

OC1(Cc2ccccc2)CCN(CCOc2ccccc2)CC1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.65
GRIN3B O60391 1/20 0.65
MAPT P10636 1/20 0.65
GRIN1 Q05586 1/20 0.65
GRIN2A Q12879 1/20 0.65
GRIN2B Q13224 1/20 0.65
GRIN2C Q14957 1/20 0.65
GRIN3A Q8TCU5 1/20 0.65
TMEM97 Q5BJF2 1/20 0.55
SIGMAR1 Q99720 1/20 0.55
LTA4H P09960 8/20 0.54
HTT P42858 1/20 0.51
DRD2 P14416 1/20 0.51
KCNA5 P22460 1/20 0.50
OPRM1 P35372 1/20 0.50
OPRD1 P41143 1/20 0.50
OPRK1 P41145 1/20 0.50
OPRL1 P41146 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6208483 0.99 GRIN2D (0.64) GRIN2DGRIN3BMAPTGRIN1GRIN2A
SCHEMBL6207790 0.93 GRIN2D (0.57) GRIN2DGRIN3BMAPTGRIN1GRIN2A
SCHEMBL6207318 0.92 GRIN2D (0.78) GRIN2DGRIN3BMAPTGRIN1GRIN2A
SCHEMBL7286173 0.92 LTA4H (0.67) GRIN2DGRIN3BMAPTGRIN1GRIN2A
SCHEMBL20228036 0.92 GRIN2D (0.56) GRIN2DGRIN3BMAPTGRIN1GRIN2A
Hydrochloric Acid SCHEMBL6207785 0.91 GRIN2D (0.76) GRIN2DGRIN3BMAPTGRIN1GRIN2A
SCHEMBL7295960 0.86 GRIN2D (0.65) GRIN2DGRIN3BMAPTGRIN1GRIN2A
SCHEMBL7289245 0.86 GRIN2D (0.79) GRIN2DGRIN3BMAPTGRIN1GRIN2A
SCHEMBL6208225 0.86 GRIN2D (0.62) GRIN2DGRIN3BMAPTGRIN1GRIN2A
SCHEMBL4692610 0.85 GRIN2D (0.69) GRIN2DGRIN3BMAPTGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP claimed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP claimed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO claimed
EP-0869792-B1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 2005-03-09 EP disclosed
US-6124323-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP disclosed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP disclosed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed